Dextromethorphan and guaifenesin use should be monitored carefully in individuals with "weak metabolizer" CYP2D6 enzyme amounts and people who are sedated. This mixture medication features a large median toxic dose (TD50) to median effective dose (ED50) ratio (or therapeutic index) in these patients. 资助维基百科 外观 创建账号 登录 个人工具 创建账号 These https://buylabradorretrieverpuppy12344.articlesblogger.com/53208231/the-smart-trick-of-dextromethorphan-dxm-for-sale-in-copyright-that-no-one-is-discussing